Scaling down imaging: molecular mapping of cancer in mice

Ralph Weissleder1

  • 1Harvard Medical School, Center for Molecular Imaging Research, Massachusetts General Hospital, Boston 02129, USA. weissleder@helix.mgh.harvard.edu

Nature Reviews. Cancer
|March 21, 2002
PubMed

Insights

Miniaturized imaging and reporter probes enable continuous in vivo monitoring of animal models for disease and therapeutic effects. These advanced techniques show promise for future clinical translation in non-invasive human cancer detection and treatment monitoring.

Area of Science:

  • Biomedical Engineering
  • Molecular Imaging
  • Preclinical Research

Background:

  • Advancements in miniaturized imaging equipment and reporter probes are crucial for studying disease in animal models.
  • Transgenic and knockout mice offer valuable platforms for in vivo disease research.

Purpose of the Study:

  • To highlight the utility of advanced imaging technologies in preclinical disease models.
  • To explore the potential translation of these techniques for human cancer diagnostics and therapeutics.

Main Methods:

  • Utilizing miniaturized imaging equipment for in vivo studies.
  • Employing reporter probes for cellular and molecular tracking.
  • Monitoring tumour development and therapeutic responses in animal models.

Main Results:

  • Continuous in vivo monitoring of tumour development is achievable.
  • Therapeutic effects on specific cell populations and molecules can be assessed.
  • The technology allows for detailed observation of disease progression and treatment efficacy.

Conclusions:

  • Miniaturized imaging and reporter probes significantly enhance the study of animal models of disease.
  • These technologies hold potential for non-invasive detection and monitoring of human cancers in clinical settings.